Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD

Clinical trial NCT07778719 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07778719
Sponsor: The 95th Hospital of Putian，Putian, Fujian, China
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes Metabolic Dysfunction-Associated Steatotic Liver Disease

Start date: 2026-10-01
Primary completion: 2027-10-10
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.